Enhancing Ezetimibe Anticancer Activity Through Development of Drug Nano-Micelles Formulations: A Promising Strategy Supported by Molecular Docking

BACKGROUND: Ezetimibe, initially recognized as a cholesterol-lowering agent, has recently attracted attention due to its potential anticancer properties. We aimed to explore an innovative approach of enhancing the drug anticancer activity through the development of drug nano-formulations. MATERIALS...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Tarek A, Ali, Ehab M M, Omar, Abdelsattar M, Almehmady, Alshaimaa M, El‐Say, Khalid M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657552/
https://www.ncbi.nlm.nih.gov/pubmed/38026536
http://dx.doi.org/10.2147/IJN.S438704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657552/
https://www.ncbi.nlm.nih.gov/pubmed/38026536
http://dx.doi.org/10.2147/IJN.S438704

Ejemplares similares